<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11860326</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.305</article-id><article-id pub-id-type="other">EPP0076</article-id><article-id pub-id-type="pii">S0924933824003055</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Alcohol and Sedative Use Disorders in the Lebanese Population: Role of Sleep and Psychiatric Factors</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chamoun</surname><given-names>K.</given-names></name><xref rid="aff0595" ref-type="aff">
<sup>1</sup></xref><xref rid="aff0596" ref-type="aff">
<sup>2</sup></xref><xref rid="aff0597" ref-type="aff">
<sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wehbe</surname><given-names>N.</given-names></name><xref rid="aff0596" ref-type="aff">
<sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Salameh</surname><given-names>P.</given-names></name><xref rid="aff0598" ref-type="aff">
<sup>4</sup></xref><xref rid="aff0599" ref-type="aff">
<sup>5</sup></xref><xref rid="aff0600" ref-type="aff">
<sup>6</sup></xref><xref rid="aff0601" ref-type="aff">
<sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sacre</surname><given-names>H.</given-names></name><xref rid="aff0598" ref-type="aff">
<sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Atallah</surname><given-names>M.</given-names></name><xref rid="aff0596" ref-type="aff">
<sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mouawad</surname><given-names>J.</given-names></name><xref rid="aff0596" ref-type="aff">
<sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rabbaa</surname><given-names>L.</given-names></name><xref rid="aff0595" ref-type="aff">
<sup>1</sup></xref><xref rid="aff0596" ref-type="aff">
<sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Megarbane</surname><given-names>B.</given-names></name><xref rid="aff0597" ref-type="aff">
<sup>3</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Hajj</surname><given-names>A.</given-names></name><xref rid="aff0595" ref-type="aff">
<sup>1</sup></xref><xref rid="aff0598" ref-type="aff">
<sup>4</sup></xref><xref rid="aff0602" ref-type="aff">
<sup>8</sup></xref><xref rid="aff0603" ref-type="aff">
<sup>9</sup></xref><xref rid="cor0166" ref-type="corresp">
<sup>*</sup>
</xref></contrib></contrib-group><aff id="aff0595">
<sup>1</sup>Laboratoire de Pharmacologie, <institution>Pharmacie Clinique et Contr&#x000f4;le de Qualit&#x000e9; des M&#x000e9;dicaments</institution></aff><aff id="aff0596">
<sup>2</sup>Faculty of Pharmacy, <institution>Saint Joseph University</institution>, <city>Beirut</city>, <country>Lebanon</country></aff><aff id="aff0597">
<sup>3</sup>Inserm, UMR-S1144, <institution>Universit&#x000e9; Paris Cit&#x000e9;</institution>, <city>Paris</city>, <country>France</country></aff><aff id="aff0598">
<sup>4</sup><institution>INSPECT-LB (Institut National de Sant&#x000e9; Publique, d&#x02019;&#x000c9;pid&#x000e9;miologie Clinique et de Toxicologie-Liban)</institution>, <city>Beirut</city></aff><aff id="aff0599">
<sup>5</sup><institution>School of Medicine, Lebanese American University</institution>, <city>Byblos</city>, <country>Lebanon</country></aff><aff id="aff0600">
<sup>6</sup>Department of Primary Care and Population Health, <institution>University of Nicosia Medical School</institution>, <city>Nicosia</city>, <country>Cyprus</country></aff><aff id="aff0601">
<sup>7</sup>Faculty of Pharmacy, <institution>Lebanese University</institution>, <city>Hadat</city>, <country>Lebanon</country></aff><aff id="aff0602">
<sup>8</sup>Faculty of Pharmacy, <institution>Universit&#x000e9; Laval</institution></aff><aff id="aff0603">
<sup>9</sup>Oncology Division, <institution>CHU de Qu&#x000e9;bec- Universit&#x000e9; Laval Research Center</institution>, <city>Quebec</city>, <country>Canada</country></aff><author-notes><corresp id="cor0166"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="280">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S131</fpage><lpage>S132</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824003055a.pdf"/><abstract><sec id="sec0996"><title>Introduction</title><p>Alcohol and sedative substance use disorders are escalating global public health challenges. Lebanon has grappled with multiple crises, including economic, healthcare, and social issues.</p></sec><sec id="sec0997"><title>Objectives</title><p>This study aimed to assess the correlates of the alcohol and sedative substance use risk scores with sociodemographic and clinical factors, including sleep disorders, chronotype, anxiety, and depression.</p></sec><sec id="sec0998"><title>Methods</title><p>A cross-sectional study was conducted among the Lebanese population using several validated scales to assess the risk of alcohol and sedative substance use, including the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST). Other tools evaluated chronotype, sleep, and mood disturbances. Bivariate and multivariable analyses were then performed, taking the alcohol and sedative scores as dependent variables.</p></sec><sec id="sec0999"><title>Results</title><p>A total of 646 participants were included. Multivariate analysis revealed positive and significant correlations between higher ASSIST-alcohol scores and personal history of alcohol abuse (B=4.61), family history of prescription substance abuse (B=1.763), psychiatric disorders (B=2.898), and worse Insomnia Severity Index scores (Beta=0.14). Conversely, ASSIST-alcohol scores negatively correlated with weight (B= -0.39) and morning chronotype (B=-0.084). Positive correlations were identified between higher ASSIST-alcohol scores and personal history of illicit substance abuse (B=2.834), prescription substance abuse (B=2.252), sleep quality (B=0.130), and sleep severity (B=0.082), while negatively correlating with cigarette smoking (B=-0.038).</p></sec><sec id="sec1000"><title>Conclusions</title><p>This study elucidates the role of several predisposing factors to alcohol and sedative use disorders in Lebanon, including history of substance abuse, psychiatric disorders, sleep disorders, and chronotype. These findings advocate, in particular, for the integration of sleep disorder assessment and management into addiction rehabilitation programs.</p></sec><sec id="sec1001"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="2"/></counts></article-meta></front></article>